Wesley Research Institute
Donate
Now

The Clinical Trials Centre at Wesley Research Institute has been managing trials since 1994. Clinical trials are a type of research involving human volunteers dedicated to offering new and emerging treatment options to patients with various illnesses and diseases.

About the Clinical Trials Centre

The purpose of a clinical trial is to evaluate new approaches in treating medical conditions or diseases under controlled conditions. This involves determining how well people respond to new treatments, what side effects there are, how well they are tolerated or whether the new intervention is better than those that are already available.

The conduct of high-quality clinical trials is not only essential in the development of new medicines and medical devices, but they are also necessary to find new uses for existing medicines.

The Clinical Trials Centre enables patient participation in national and international phase I-IV clinical trials with a focus on evaluating new therapies, drugs, and diagnostic tools to drive discoveries into standard clinical practice. 

Engaged across four hospitals – The Wesley Hospital, St Andrew’s War Memorial Hospital, Buderim Private Hospital and St Stephen’s (Hervey Bay) – clinicians and patients located in both metropolitan and regional areas can participate.

Our patients are at the heart of all we do and that’s why Wesley Research Institute focuses on providing participants, researchers, and sponsors with a first-class, professional experience.  Our dedicated staff strive for a reputation of integrity and quality, delivering a warm, caring and inviting environment for all participants.

What clinical trials mean to participants

Clinical trials at Wesley Research Institute

PROSERA

Closed for patient recruitment
The purpose of this research study is to determine whether seralutanib is safe and effective when given to people with PAH who are already taking other PAH medications.  

INSIGNIA

Closed for patient recruitment
This trial is testing a new investigational medication in adults with high blood pressure in the lungs (pulmonary hypertension or PH) related to chronic obstructive pulmonary disease (COPD)

Lightray OLE

Closed for patient recruitment
The purpose of this study is to allow participants from the LIGHTRAY trial to continue getting MK-7962 by weight-banded dosing (dose based on weight bands with a different dose assigned to each band).  

Phocus

Closed for patient recruitment
The purpose of this research study is to assess the safety and tolerability of inhaled mosliciguat by dry-powder inhaler once daily for adults aged 18-80 years of age diagnosed with Interstitial Lung Disease

APEX

Closed for patient recruitment
The study will help us to understand if TX000045 improves blood flow from the lungs back to the heart, improves filling of participants’ hearts with blood and improves participants’ ability to exercise for patients with Pulmonary Hypertension.
Showing
Donate
to support research

Contact Us

For more information or if you would like to discuss a new Clinical Trial please contact our team:

Email: [email protected]

Phone:  07 3721 1500

Facilities

Wesley Research Institute is swipe card access only and is located on the 8th Floor of the East Wing of The Wesley Hospital.

It offers the following facilities for clinical trials:

  • Four clinical consultation rooms
  • Pathology Laboratory (including 2x vaccine refrigerators with back to base alarms and 24/7 temperature monitoring)
  • Dedicated drug safe
  • Two Patient Observation Lounges
  • Treatment Room
  • 3 x -80˚C freezers
  • -20˚C freezer
  • Refrigerated centrifuge
  • 3 x ambient centrifuges
  • Secure document storage
  • Ample monitoring space
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram